← Open Payments lookup

PHILIP ELANGWE: Open Payments

NPI 1780776435 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$984 in 51 payments from 17 companies in 2025. Trend: 2023 $1,750 · 2024 $1,453 · 2025 $984

Food & beverage: $984
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP10$285
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)15$155
ABBVIE INC.4$76
Otsuka America Pharmaceutical, Inc.3$72
GlaxoSmithKline, LLC.4$62
Bayer Healthcare Pharmaceuticals Inc.3$60
Vanda Pharmaceuticals Inc.2$55
Aimmune Therapeutics, Inc.1$35
Teva Pharmaceuticals USA, Inc.1$30
Inspire Medical Systems, Inc.1$25

Products named: BREZTRI, CAPLYTA, REXULTI, FARXIGA, Kerendia, VRAYLAR, TRELEGY ELLIPTA, AIRSUPRA.

Industry payments across AR — which companies pay providers there.